Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 Current Ratio is 7.53 as of Mar. 2026, which is 78% above its 10-year median of 4.22. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,995 Consumer Packaged Goods companies, Sheel Biotech ranks better than 93.53% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sheel Biotech's current ratio for the quarter that ended in Mar. 2026 was 7.53.
Sheel Biotech has a current ratio of 7.53. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Sheel Biotech's Current Ratio or its related term are showing as below:
NSE:SHEEL'
s Current Ratio Range Over the Past 10 Years
Min: 4.04 Med: 4.22 Max: 7.53
Current: 7.53
During the past 5 years, Sheel Biotech's highest Current Ratio was 7.53. The lowest was 4.04. And the median was 4.22.
NSE:SHEEL's Current Ratio is ranked better than 93.53% of 1995
companies
in the Consumer Packaged Goods industry
Industry Median: 1.73
vs NSE:SHEEL: 7.53
Sheel Biotech (NSE:SHEEL) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Sheel Biotech Current Ratio Related Terms
Sheel Biotech Current Ratio Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech Current Ratio Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Current Ratio
4.25
4.04
4.22
4.21
7.53
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Current Ratio
4.25
4.04
4.22
4.21
7.53
NSE:SHEEL vs ADM, BG, TSN: Current Ratio Comparison
For the Farm Products subindustry, Sheel Biotech's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's Current Ratio distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech (NSE:SHEEL) has a Current Ratio of 7.53 as of Mar. 2026. This is 78% above median its historical median of 4.22. Over the past decade, Sheel Biotech's Current Ratio has ranged from 4.04 to 7.53. According to the industry distribution chart, Sheel Biotech ranks #129 out of 1995 companies in the Consumer Packaged Goods industry, placing it in the top 6.5%.
Is Sheel Biotech's Current Ratio too high?
Sheel Biotech's current Current Ratio of 7.53 is 78% above median its 10-year median of 4.22. Over the past 10 years, this metric has ranged from a low of 4.04 to a high of 7.53. The Consumer Packaged Goods industry median Current Ratio is 1.73. Sheel Biotech's value of 7.53 is 335.3% above this industry median. Based on the distribution chart, Sheel Biotech ranks #129 out of 1995 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Current Ratio compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #129 out of 1995 companies for Current Ratio. This places Sheel Biotech in the top 7% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.73. Sheel Biotech's value of 7.53 is 335.3% above this benchmark. Historically, Sheel Biotech's own Current Ratio has ranged from 4.04 to 7.53 over the past decade. While the company's 10-year median is 4.22 vs. the industry median of 1.73, Sheel Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,995 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current Current Ratio of 7.53 is 335.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current Current Ratio is 7.53, which is 78% above median its own 10-year median of 4.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Current Ratio of 7.53. The current Current Ratio is 7.53, which is 78% above median its 10-year median of 4.22 and 335.3% above the Consumer Packaged Goods industry median of 1.73. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Current Ratio is 7.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
